berberine has been researched along with sb 203580 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, JD; Kong, WJ; Li, ZR; Pan, HN; Shan, N; Si, SY; Song, DQ; Wang, YM; Wei, J; Xue, R; Yang, P; You, XF; Zhang, H; Zhao, LX; Zhao, W; Zhou, ZX | 1 |
| Chenge, J; Cok, A; Louters, LL; Oram, DS; Plaisier, C; Salie, MJ | 1 |
| Liu, Y; Shi, HL; Wu, XJ; Xie, JQ | 1 |
| Eo, SH; Kim, JH; Kim, SJ | 1 |
| He, B; Liu, SQ; Mei, HJ; Wu, SH; Xia, SQ; Yu, L; Zhao, Q; Zhou, Y | 1 |
| Chen, X; Liu, C; Qu, S; Wen, X; Yang, Y; Zhang, X | 1 |
6 other study(ies) available for berberine and sb 203580
| Article | Year |
|---|---|
Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression.
Topics: Animals; Berberine; Cell Line, Tumor; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Imidazoles; Insulin Resistance; Male; Mice; Mice, Inbred NOD; Protein Kinase C; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Wistar; Receptor, Insulin; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Small Interfering; Up-Regulation | 2009 |
Berberine acutely activates the glucose transport activity of GLUT1.
Topics: AMP-Activated Protein Kinases; Animals; Berberine; Biological Transport; Cell Line; Deoxyglucose; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Flavonoids; Glucose; Glucose Transporter Type 1; Imidazoles; Kinetics; Mice; p38 Mitogen-Activated Protein Kinases; Pyrazoles; Pyridines; Pyrimidines | 2011 |
Berberine counteracts enhanced IL-8 expression of AGS cells induced by evodiamine.
Topics: Antineoplastic Agents, Phytogenic; Berberine; Cell Adhesion; Cell Cycle; Cell Movement; Cell Proliferation; Chemokines; Chemokines, CXC; Chromones; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Intercellular Adhesion Molecule-1; Interleukin-8; Morpholines; Pyridines; Quinazolines; Signal Transduction; Stomach Neoplasms; Tumor Cells, Cultured | 2013 |
Induction of G₂/M Arrest by Berberine via Activation of PI3K/Akt and p38 in Human Chondrosarcoma Cell Line.
Topics: Berberine; CDC2 Protein Kinase; cdc25 Phosphatases; Cell Line, Tumor; Cell Proliferation; Chondrosarcoma; Chromones; Cyclin B1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Enzyme Activation; G2 Phase Cell Cycle Checkpoints; Humans; Imidazoles; Morpholines; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyridines; Retinoblastoma Protein; Tumor Suppressor Protein p53; Up-Regulation | 2014 |
Berberine prevents nitric oxide-induced rat chondrocyte apoptosis and cartilage degeneration in a rat osteoarthritis model via AMPK and p38 MAPK signaling.
Topics: Alkaloids; AMP-Activated Protein Kinases; Animals; Animals, Newborn; Apoptosis; Apoptosis Regulatory Proteins; Berberine; Cartilage, Articular; Cell Survival; Chondrocytes; Cytoskeleton; Disease Models, Animal; Imidazoles; Knee Joint; Male; Nitric Oxide; Nitroprusside; Osteoarthritis; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Signal Transduction; Vidarabine | 2015 |
Coptisine induces G2/M arrest in esophageal cancer cell via the inhibition of p38/ERK1/2/claudin-2 signaling pathway.
Topics: Antineoplastic Agents; Berberine; CDC2 Protein Kinase; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Claudin-2; Cyclin B1; Esophageal Neoplasms; G2 Phase Cell Cycle Checkpoints; Humans; Imidazoles; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Pyrazoles; Pyridines; Pyrroles; Signal Transduction | 2021 |